Value of interim FDG PET/CT for predicting outcome of patients with angioimmunoblastic T-cell lymphoma
Seung Hwan Moon(Samsung Medical Center), Kyung-Han Lee(Samsung (South Korea)), Ah Young Lee(Samsung Medical Center), Young Seok Cho(Samsung Medical Center), Won-Seog Kim(Samsung Medical Center), Seok Jin Kim(Samsung (South Korea)), Byung‐Tae Kim(Samsung Medical Center), Yearn Seong Choe(Samsung Medical Center)
Cited by 15
Related Papers
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project
|Blood|2011|431
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma
|New England Journal of Medicine|2022|342
Akt Participation in the Wnt Signaling Pathway through Dishevelled
|Journal of Biological Chemistry|2001|338